- 178.3k views
Overview of fellowship courses offered by Medvarsity and Medanta in Cardiology
In India, the prevalence of heart disease is dangerously rising. With 1.7 million fatalities each year, heart disease is the main cause of death in India. Nearly one-fourth of all fatalities in India, according to the global burden of disease study, are caused by cardiovascular disorders. There is a severe lack of qualified cardiologists in India despite the country's growing cardiovascular disease burden. The country needs 88,000 more cardiologists than the 4000 that are now available. To fill this gap in the demand for cardiac services, there is a need for doctors. The Fellowship in Clinical, Preventive & Non-Invasive Cardiology is a joint program created by Medanta Heart Institute and Medvarsity Online Ltd to develop a pool of skilled clinical and non-interventional cardiologists to address the increasing demand for cardiology services in India. The student will receive 2-years of on-job training in clinical, preventive, and non-invasive cardiology as part of this course. This will include clinical training of 6 months in cardiac ICU, 3 months in cardiac inpatient wards, and 3 months in cardiac OPDs. The student will also get 12 months of non-invasive cardiac diagnostics training including echocardiography, cardiac stress testing, nuclear imaging, and other imaging methods.
About the Speaker

Dr. R.R. Kasliwal
Chairman- Divison of Clinical & Preventive Cardiology,Adjunct Professor for NBE,Medanta Heart city
Upcoming Case Discussions
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Congenital Uterine Anomalies
Congenital uterine anomalies are structural abnormalities of the uterus resulting from improper fusion, canalization, or resorption of the Müllerian ducts during fetal development. These anomalies include septate, bicornuate, unicornuate, and didelphys uterus, among others. They can be asymptomatic or associated with infertility, recurrent pregnancy loss, preterm birth, or abnormal menstruation. Diagnosis is typically made using imaging modalities like ultrasound, MRI, or hysterosalpingography. Treatment depends on the type and severity of the anomaly, with surgical correction such as hysteroscopic septum resection often indicated in symptomatic cases. Early detection is crucial for optimizing reproductive outcomes and guiding appropriate management strategies.
Management of Postoperative Pain: Best Practices for GP’s
Effective management of postoperative pain is crucial for promoting recovery and preventing complications. General practitioners should start by assessing pain severity using appropriate scales, then tailor the treatment plan based on the patient's medical history and the type of surgery. A combination of pharmacological approaches, such as non-opioid analgesics (e.g., NSAIDs) and opioids when necessary, should be used to minimize pain while reducing the risk of addiction. Multimodal strategies, including physical therapy and non-pharmacological techniques like cold therapy or mindfulness, can further enhance pain relief. Close follow-up is essential to adjust the treatment as needed and ensure the patient's pain is well-controlled.
Diabetes and Stem Cells: What Does the Future Hold?
The future of diabetes treatment may be revolutionized by stem cell research, offering hope for a long-term cure. Scientists are developing stem cell therapies that could regenerate insulin-producing beta cells in the pancreas, potentially restoring natural insulin production in people with type 1 diabetes. Early clinical trials have shown promising results, with some patients reducing or eliminating their need for insulin injections. While challenges like immune rejection and long-term efficacy remain, continued advancements suggest stem cell therapy could significantly change diabetes management in the coming years.